Zurich Cantonal Bank
PACB icon

Zurich Cantonal Bank’s Pacific Biosciences PACB Stock Holding History

Zurich Cantonal Bank’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,582
Closed -$25.4K – 3226
2025
Q4 		$25.4K Buy
+13,582
New +$26.1K ﹤0.01% 2460

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Zurich Cantonal Bank's PACB Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Pacific Biosciences (PACB) in Q1 2026: 9,146 shares worth $12.1K. The stake represents ﹤0.01% of the portfolio and ranks #2475 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in PACB as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in PACB in Q4 2015 and has held it in 41 quarters since. The position peaked at $1.19M in Q2 2021. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Zurich Cantonal Bank held 9,146 shares of Pacific Biosciences worth $12.1K as of Q1 2026.
  • Pacific Biosciences was a new Zurich Cantonal Bank position in Q1 2026.
  • Pacific Biosciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2475 holding.
  • Zurich Cantonal Bank first reported a position in Pacific Biosciences in Q4 2015 and has held it in 41 quarters since.
  • Zurich Cantonal Bank's Pacific Biosciences position peaked at $1.19M in Q2 2021.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.